Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “CABOTEGRAVIR”

120 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 120 results

Early research (Phase 1)Study completedNCT03149848
What this trial is testing

Effect of Rifabutin on the Pharmacokinetics of Oral Cabotegravir in Healthy Subjects

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 15
Testing effectiveness (Phase 2)Study completedNCT02076178
What this trial is testing

Study to Evaluate the Safety Tolerability and Acceptability of Long Acting Injections of the Human Immunodeficiency Virus (HIV) Integrase Inhibitor, GSK1265744, in HIV Uninfected Men (ECLAIR)

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 127
Early research (Phase 1)Study completedNCT02799264
What this trial is testing

Evaluate the Effect of High Fat Meal on Cabotegravir

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 24
Not applicableNot Yet RecruitingNCT07346508
What this trial is testing

Project SPEED - Streamlined Protocol for Early Engagement and Delivery of HIV Prevention With Long-acting Injectable Cabotegravir: A Nurse-driven Protocol

Who this might be right for
HIV (Human Immunodeficiency Virus)
KC Care Health Center 250
Not applicableActive Not RecruitingNCT06518408
What this trial is testing

A Real-life Study of the Use of Cabotegravir Plus Rilpivirine Long-acting in ART-experienced Pre-treated People With HIV

Who this might be right for
Human Immunodeficiency Virus
University Hospital Virgen de las Nieves 287
Not applicableNot Yet RecruitingNCT07516548
What this trial is testing

Pharmacokinetic Study of Long-acting Antiretrovirals and Contraceptives in HIV

Who this might be right for
HIV InfectionsContraceptionDrug-drug Interaction+2 more
University of Alabama at Birmingham 105
Not applicableStudy completedNCT05152953
What this trial is testing

Preparing for Pharmacy-based Delivery of Long-acting Injectable Antiretroviral Therapy (LAI-ART)

Who this might be right for
Hiv
University of California, San Francisco 63
Testing effectiveness (Phase 2)Study completedNCT04824131
What this trial is testing

Safety, Tolerability and Acceptability of Long-Acting Cabotegravir (CAB LA) for the Prevention of HIV Among Adolescent Females

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Testing effectiveness (Phase 2)Study completedNCT03497676
What this trial is testing

More Options for Children and Adolescents (MOCHA): Oral and Long-Acting Injectable Cabotegravir and Rilpivirine in HIV-Infected Children and Adolescents

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 168
Early research (Phase 1)Study completedNCT05776108
What this trial is testing

Assess the Food Effect and the Relative Bioavailability of the Cabotegravir (CAB) Pediatric Dispersible Tablet (DT) Formulation

Who this might be right for
HIV Infections
ViiV Healthcare 24
Early research (Phase 1)Study completedNCT02478463
What this trial is testing

Pharmacokinetic Study of Cabotegravir Long-acting in Healthy Adult Volunteers

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 19
Not applicableUnknownNCT05697289
What this trial is testing

Satisfaction of HIV-infected Patients Treated With Cabotegravir-rilpivirine Injectable Dual Therapy

Who this might be right for
HIV Infections
Assistance Publique - Hôpitaux de Paris 150
Early research (Phase 1)Study completedNCT01754116
What this trial is testing

Study to Assess the Relative Bioavailability of New Formulations of GSK1265744 Long Acting Parental (LAP) in Healthy Adult Subjects

Who this might be right for
Infection, Human Immunodeficiency Virus
ViiV Healthcare 43
Large-scale testing (Phase 3)UnknownNCT06138600
What this trial is testing

Acceptability and Feasibility of Injectable Cabotegravir Pre-exposure Prophylaxis (PrEP) Versus Oral PrEP in Routine Care up to 15 Months in Private Pharmacies in South Africa

Who this might be right for
HIV Infections
University of Witwatersrand, South Africa 200
Large-scale testing (Phase 3)Active Not RecruitingNCT06694805
What this trial is testing

Evaluate the Effectiveness of Long-acting (LA) Cabotegravir (CAB) + Rilpivirine (RPV) LA When Given to Participants With Detectable HIV-1

Who this might be right for
HIV Infections
ViiV Healthcare 326
Large-scale testing (Phase 3)Not Yet RecruitingNCT06273943
What this trial is testing

Impact of Long-acting Injectable Cabotegravir for HIV PrEP in MSM in France.

Who this might be right for
Prevention
ANRS, Emerging Infectious Diseases 322
Not applicableNot Yet RecruitingNCT06403865
What this trial is testing

Patient-Reported Outcomes in Real-life of Cabotegravir and Rilpivirine

Who this might be right for
Quality of Life
University Paris 7 - Denis Diderot 280
Large-scale testing (Phase 3)Study completedNCT04399551
What this trial is testing

A Study Evaluating Implementation Strategies for Cabotegravir (CAB)+ Rilpivirine (RPV) Long-acting (LA) Injectables for Human Immunodeficiency Virus (HIV)-1 Treatment in European Countries

Who this might be right for
HIV Infections
ViiV Healthcare 437
Testing effectiveness (Phase 2)Study completedNCT01641809
What this trial is testing

Dose Ranging Study of GSK1265744 Plus Nucleoside Reverse Transcriptase Inhibitors for Induction of Human Immunodeficiency Virus-1 (HIV-1) Virologic Suppression Followed by Virologic Suppression Maintenance by GSK1265744 Plus Rilpivirine

Who this might be right for
Infection, Human Immunodeficiency VirusHIV Infections
ViiV Healthcare 244
Early research (Phase 1)Study completedNCT04484337
What this trial is testing

Study to Evaluate Pharmacokinetic (PK), Safety and Tolerability of Cabotegravir (CAB) 400 Milligrams Per Milliliter (mg/mL) Formulation in Healthy Adult Participants

Who this might be right for
HIV Infections
ViiV Healthcare 138
Next Page